Potential of Atypical Antipsychotics in the Treatment of Nonpsychotic Disorders

[1]  C. McDougle,et al.  Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[2]  D. Stein,et al.  Clozapine and tardive dyskinesia: analysis of clinical trials , 1996 .

[3]  C. McDougle,et al.  A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. , 1996, Archives of general psychiatry.

[4]  A. Hardan,et al.  Case study: risperidone treatment of children and adolescents with developmental disorders. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  C. McDougle,et al.  Effects of tryptophan depletion in drug-free adults with autistic disorder. , 1996, Archives of general psychiatry.

[6]  C. McDougle,et al.  A Risk-Benefit Assessment of Drugs Used in the Management of Obsessive-Compulsive Disorder , 1996, Drug safety.

[7]  A. Bystritsky,et al.  Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. , 1996, The Journal of clinical psychiatry.

[8]  E. Soucar,et al.  Tics and risperidone. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  B. Peterson,et al.  TICS AND RISPERIDONE , 1996 .

[10]  T. Byrne,et al.  Case study: anorexia nervosa and autistic disorder in an adolescent girl. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  C. McDougle,et al.  Obsessive-compulsive symptoms with-neuroleptics. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[12]  M. Tohen,et al.  Risperidone in the treatment of mania. , 1996, The Journal of clinical psychiatry.

[13]  P. Muglia,et al.  Clinical effects of clozapine on autistic disorder. , 1996, The American journal of psychiatry.

[14]  M. Jenike,et al.  Trichotillomania and carpal tunnel syndrome. , 1996, The Journal of clinical psychiatry.

[15]  Schaffer Cb,et al.  The use of risperidone in the treatment of bipolar disorder. , 1996 .

[16]  D. J. Kamphuis,et al.  Use of clozapine in tardive dystonia , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  C. McDougle,et al.  Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. , 1995, The American journal of psychiatry.

[18]  S. Schulz,et al.  Violence and schizophrenia: clozapine as a specific antiaggressive agent. , 1995, The Bulletin of the American Academy of Psychiatry and the Law.

[19]  S. Madhusoodanan,et al.  Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. , 1995, The Journal of clinical psychiatry.

[20]  M. Riddle,et al.  Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  C. McDougle,et al.  Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. , 1995, The Journal of clinical psychiatry.

[22]  J. Rapoport,et al.  Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  R. Weizman,et al.  Case study: emergence of transient compulsive symptoms during treatment with clothiapine. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  Azorin Jm.  Long-term treatment of mood disorders in schizophrenia. , 1995 .

[25]  D. Russo,et al.  Tardive dyskinesia revisited. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[26]  M. Tohen,et al.  Clozapine in severe mood disorders. , 1995, The Journal of clinical psychiatry.

[27]  C. McDougle,et al.  Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  Jacobsen Fm,et al.  Risperidone in the treatment of affective illness and obsessive-compulsive disorder. , 1995 .

[29]  Goodnick Pj.  Risperidone treatment of refractory acute mania. , 1995 .

[30]  Streichenwein Sm,et al.  A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. , 1995 .

[31]  P. Czobor,et al.  Effect of risperidone on hostility in schizophrenia. , 1995, Journal of clinical psychopharmacology.

[32]  F. Trémeau,et al.  Clozapine in tardive Tourette syndrome , 1995, Biological Psychiatry.

[33]  W. Jeanblanc,et al.  Risperidone for treating dementia-associated aggression. , 1995, The American journal of psychiatry.

[34]  S. Ghaemi,et al.  Is there a relationship between clozapine and obsessive-compulsive disorder?: a retrospective chart review. , 1995, Comprehensive psychiatry.

[35]  W. Weiner,et al.  Risperidone in Gilles de la Tourette syndrome , 1995, Neurology.

[36]  Smith Ea,et al.  Prolonged erection associated with risperidone treatment. , 1995 .

[37]  Giakas Wj.  Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder. , 1995 .

[38]  M. D. Banov,et al.  Is clozapine a mood stabilizer? , 1995, The Journal of clinical psychiatry.

[39]  L. Pantoni,et al.  Abnormal penetration of haptoglobin through the blood-brain-barrier (BBB) into the cerebro-spinal fluid (CSF) in Alzheimer's disease patients. , 1995, Acta Neurologica Scandinavica.

[40]  G. Hamann,et al.  What is the relevance of the endothelins in subarachnoid haemorrhage? , 1995, Journal of neurology, neurosurgery, and psychiatry.

[41]  A. Lang,et al.  Remoxipride in Parkinson's disease: differential response in patients with dyskinesias fluctuations versus psychosis. , 1995, Clinical neuropharmacology.

[42]  P. P. Kost,et al.  Clozapine in aggression. , 1995, Psychiatric services.

[43]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[44]  C. Pfeiffer,et al.  Clozapine therapy for Parkinson's disease and other movement disorders. , 1994, American journal of hospital pharmacy.

[45]  D. Fuchs.  Clozapine treatment of bipolar disorder in a young adolescent. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  W. Honer,et al.  Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. , 1994, The American journal of psychiatry.

[47]  G. Remington,et al.  Risperidone and obsessive-compulsive symptoms. , 1994, Journal of clinical psychopharmacology.

[48]  A. Labelle,et al.  Risperidone in the Treatment of Pervasive Developmental Disorder , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[49]  A. Cools,et al.  Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine. , 1994, European journal of pharmacology.

[50]  K. Phillips,et al.  Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases , 1994, Biological Psychiatry.

[51]  J. Calabrese,et al.  Clozapine in treatment-refractory mood disorders. , 1994, The Journal of clinical psychiatry.

[52]  D. Lowe,et al.  Clozapine promotes approach-oriented behavior in male mice. , 1994, The Journal of clinical psychiatry.

[53]  S. Schulz,et al.  Obsessive–compulsive symptoms and clozapine , 1994, British Journal of Psychiatry.

[54]  J. Gerlach,et al.  Motor and mental side effects of clozapine. , 1994, The Journal of clinical psychiatry.

[55]  P. Keck,et al.  Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder , 1994, The Lancet.

[56]  T. Klockgether,et al.  New medical and surgical treatments for Parkinson's disease , 1994, Current opinion in neurology.

[57]  M. Reveley,et al.  Obsessive–compulsive symptoms and clozapine , 1994, British Journal of Psychiatry.

[58]  M. D. Banov,et al.  Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. , 1994, The Journal of clinical psychiatry.

[59]  E. Tolosa,et al.  New and emerging strategies for improving levodopa treatment. , 1994, Neurology.

[60]  G. Vaiva,et al.  Dose-dependent stuttering and dystonia in a patient taking clozapine. , 1994, The American journal of psychiatry.

[61]  Laporta Ld.  More on obsessive-compulsive symptoms and clozapine. , 1994 .

[62]  Young Cr,et al.  Clozapine and refractory obsessive-compulsive disorder: a case report. , 1994 .

[63]  M. Eales,et al.  Exacerbation of Obsessive–Compulsive Symptoms Associated with Clozapine , 1994, British Journal of Psychiatry.

[64]  U. Bonuccelli,et al.  Clozapine in Huntington's chorea , 1994, Neurology.

[65]  C. McDougle,et al.  Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. , 1994, Archives of general psychiatry.

[66]  E. Jansen.  Clozapine in the treatment of tremor in Parkinson's disease , 1994, Acta neurologica Scandinavica.

[67]  G. D. de Moore,et al.  Harakiri: a clinical study of deliberate self-stabbing. , 1994, The Journal of clinical psychiatry.

[68]  C. McDougle,et al.  The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. , 1993, The Psychiatric clinics of North America.

[69]  M. Zompo,et al.  A double‐blind study of L‐sulpiride versus amitriptyline in lithium‐maintained bipolar depressives , 1993, Acta psychiatrica Scandinavica.

[70]  J. Azorin,et al.  Clozapine in the Treatment of Psychotic Refractory Depression , 1993, British Journal of Psychiatry.

[71]  J. Lieberman.  Understanding the Mechanism of Action of Atypical Antipsychotic Drugs , 1993, British Journal of Psychiatry.

[72]  F. Frankenburg,et al.  Clozapine treatment of borderline patients: a preliminary study. , 1993, Comprehensive psychiatry.

[73]  W. Löscher,et al.  The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol. , 1993, European journal of pharmacology.

[74]  V. Lerner,et al.  Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine. , 1993, The Journal of nervous and mental disease.

[75]  J. Cummings,et al.  The neuroanatomy of depression. , 1993, The Journal of clinical psychiatry.

[76]  E. Hollander,et al.  Clozapine, obsessive symptoms, and serotonergic mechanisms. , 1993, The American journal of psychiatry.

[77]  J. Bennett,et al.  Suppression of dyskinesias in advanced Parkinson's disease , 1993, Neurology.

[78]  J. Volavka,et al.  Clozapine effects on hostility and aggression in schizophrenia. , 1993, Journal of clinical psychopharmacology.

[79]  E. Češková,et al.  Double-blind Comparison of Risperidone and Haloperidol in Schizophrenic and Schizoaffective Psychoses , 1993, Pharmacopsychiatry.

[80]  P. Czobor,et al.  Long-term high-dose neuroleptic treatment: who gets it and why? , 1993, Hospital & community psychiatry.

[81]  C. Leveroni,et al.  The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. , 1993, The Journal of clinical psychiatry.

[82]  J. Lamberti,et al.  Clozapine in a bipolar depressed patient. , 1993, The American journal of psychiatry.

[83]  M. Crismon,et al.  Clozapine response and adverse effects in nine brain-injured patients. , 1993, Journal of clinical psychopharmacology.

[84]  H. Hartman,et al.  Effects of atypical antipsychotic agents on social behavior in rodents , 1993, Pharmacology Biochemistry and Behavior.

[85]  R. Tandon,et al.  Development of obsessive-compulsive symptoms during clozapine treatment. , 1993, The American journal of psychiatry.

[86]  C. McDougle,et al.  Pharmacotherapy of obsessive compulsive disorder. , 1993, The Journal of clinical psychiatry.

[87]  P. Thiry,et al.  Risperidone as add‐on therapy in behavioural disturbances in mental retardation: a double‐blind placebo‐controlled cross‐over study , 1993, Acta psychiatrica Scandinavica.

[88]  S. Steingard,et al.  Emergence of obsessive compulsive symptoms during treatment with clozapine. , 1992, The Journal of clinical psychiatry.

[89]  S. Swedo,et al.  Trichotillomania. An obsessive compulsive spectrum disorder? , 1992, The Psychiatric clinics of North America.

[90]  M. Stanley,et al.  Clinical characteristics of trichotillomania and its response to fluoxetine. , 1992, The Journal of clinical psychiatry.

[91]  S. Braman,et al.  Polyserositis associated with clozapine treatment. , 1992, The American journal of psychiatry.

[92]  N. Moore,et al.  The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. , 1992, The Journal of pharmacology and experimental therapeutics.

[93]  T. Suppes,et al.  Clozapine in the treatment of dysphoric mania , 1992, Biological Psychiatry.

[94]  W. Wilson.  Clinical review of clozapine treatment in a state hospital , 1992, Schizophrenia Research.

[95]  R. Ganguli,et al.  Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients? , 1992, The Journal of clinical psychiatry.

[96]  B. Eichelman.  Aggressive behavior: from laboratory to clinic. Quo vadit? , 1992, Archives of general psychiatry.

[97]  E. Hollander,et al.  Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania D.J. Stein, E. Hollander New York State Psychiatric Institute, New York, NY 10032 , 1992, Biological Psychiatry.

[98]  G. Klerman,et al.  Drug Treatment of Panic Disorder: Comparative Efficacy of Alprazolam, Imipramine, and Placebo , 1992, British Journal of Psychiatry.

[99]  D. Behar,et al.  Development of transient obsessive-compulsive symptoms during treatment with clozapine. , 1992 .

[100]  J. Calabrese,et al.  Clozapine prophylaxis in rapid cycling bipolar disorder. , 1991, Journal of clinical psychopharmacology.

[101]  G. Christenson,et al.  A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. , 1991, The American journal of psychiatry.

[102]  C. McDougle,et al.  A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. , 1991, Journal of clinical psychopharmacology.

[103]  J. Lieberman,et al.  The Effects of Clozapine on Tardive Dyskinesia , 1991, British Journal of Psychiatry.

[104]  R. Baldessarini,et al.  Clozapine. A novel antipsychotic agent. , 1991, The New England journal of medicine.

[105]  R. Heel,et al.  Remoxipride , 1990, Drugs.

[106]  J. Perregaard,et al.  Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat. , 1990, European journal of pharmacology.

[107]  C. McDougle,et al.  Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. , 1990, The American journal of psychiatry.

[108]  C. McDougle,et al.  Obsessive-compulsive disorder: recent neurobiological developments , 1990 .

[109]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[110]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.

[111]  A. Shapiro,et al.  Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. , 1989, Archives of general psychiatry.

[112]  J. C. Stoof,et al.  Biochemical profile of risperidone, a new antipsychotic. , 1988, The Journal of pharmacology and experimental therapeutics.

[113]  D. Mcniel,et al.  Predictors of violence in civilly committed acute psychiatric patients. , 1988, The American journal of psychiatry.

[114]  S. Clissold,et al.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. , 1987, Drugs.

[115]  S. Yudofsky,et al.  Pharmacologic Treatment of Aggression , 1987 .

[116]  A. M. Rossi,et al.  Characteristics of Psychiatric Patients Who Engage in Assaultive or Other Fear-Inducing Behaviors , 1986, The Journal of nervous and mental disease.

[117]  A. Shapiro,et al.  Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. , 1983, Archives of general psychiatry.

[118]  T. Craig.  An epidemiologic study of problems associated with violence among psychiatric inpatients. , 1982, The American journal of psychiatry.

[119]  E. Caine,et al.  The trial use of clozapine for abnormal involuntary movement disorders. , 1979, The American journal of psychiatry.

[120]  M. Pachter.  A clinical evaluation of chlorpromazine therapy in chronic schizophrenics. , 1957, The American journal of psychiatry.

[121]  J. Calabrese,et al.  Clozapine for treatment-refractory mania. , 1996, The American journal of psychiatry.

[122]  H. Demb.  Risperidone in young children with pervasive developmental disorders and other developmental disabilities. , 1996, Journal of child and adolescent psychopharmacology.

[123]  B. Peterson.  Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. , 1996, The Journal of clinical psychiatry.

[124]  J. Rotrosen,et al.  The relationship between clozapine and obsessive-compulsive disorder. , 1996, Comprehensive psychiatry.

[125]  S. Cohen,et al.  Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. , 1996, Psychopharmacology bulletin.

[126]  L. Thompson,et al.  Cognitive-behavioral therapy and treatment for late-life depression. , 1996, The Journal of clinical psychiatry.

[127]  S. Marder.  Clinical experience with risperidone. , 1996, The Journal of clinical psychiatry.

[128]  Schulte Hm,et al.  Withdrawal dyskinesia after abrupt cessation of clozapine and benztropine. , 1996 .

[129]  G. Maina,et al.  Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD). , 1996, Psychopharmacology bulletin.

[130]  G. Chouinard,et al.  A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. , 1996, The Journal of clinical psychiatry.

[131]  A. Gelenberg,et al.  Antipsychotics in bipolar disorder. , 1996, The Journal of clinical psychiatry.

[132]  S. Strakowski,et al.  New developments in the pharmacologic treatment of schizoaffective disorder. , 1996, The Journal of clinical psychiatry.

[133]  S. Fisman,et al.  Use of risperidone in pervasive developmental disorders: a case series. , 1996, Journal of child and adolescent psychopharmacology.

[134]  H. Westenberg,et al.  Remoxipride in Adolescents with Tourette's Syndrome : An Open Pilot Study , 1995 .

[135]  N. Carrey,et al.  Risperidone Effects in Treatment-Resistant Adolescents: Preliminary Case Reports , 1995 .

[136]  J. Calabrese,et al.  A medication algorithm for treatment of bipolar rapid cycling? , 1995, The Journal of clinical psychiatry.

[137]  S. Strakowski,et al.  Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. , 1995, The Journal of clinical psychiatry.

[138]  C. McDougle,et al.  Risperidone in Adults with Autism or Pervasive Developmental Disorder , 1995 .

[139]  J. Volavka.  Neurobiology of violence , 1995 .

[140]  C. van der Linden,et al.  Serotonin‐dopamine antagonist and Gilles de la tourette's syndrome: An open pilot dose‐titration study with risperidone , 1994, Movement disorders : official journal of the Movement Disorder Society.

[141]  J. Bennett,et al.  Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reduction , 1994, Movement disorders : official journal of the Movement Disorder Society.

[142]  C. McDougle,et al.  Recent Advances in the Pharmacotherapy of Autism and Related Conditions , 1994 .

[143]  Gelenberg Aj,et al.  Treatment of bipolar disorder: how far have we come? , 1994 .

[144]  J. Friedman.  Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases , 1994, Movement disorders : official journal of the Movement Disorder Society.

[145]  D. Cohen,et al.  Developmental psychopathology and neurobiology of Tourette's syndrome. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[146]  J. Gerlach,et al.  Drug treatment of schizophrenia: myths and realities , 1994 .

[147]  R. Joffe,et al.  Combined SSRI-moclobemide treatment of psychiatric illness. , 1994, The Journal of clinical psychiatry.

[148]  L. D. Laporta.  More on obsessive-compulsive symptoms and clozapine. , 1994, The Journal of clinical psychiatry.

[149]  J. Ratey,et al.  The psychopharmacology of aggression: toward a new day. , 1993, Psychopharmacology bulletin.

[150]  L. Koran,et al.  Fluoxetine for trichotillomania: an open clinical trial. , 1992, Psychopharmacology bulletin.

[151]  A. Megens,et al.  Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol. , 1992, The Journal of pharmacology and experimental therapeutics.

[152]  J. Friedman,et al.  Clozapine‐responsive tremor in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[153]  C. McDougle,et al.  Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? , 1990, The Journal of clinical psychiatry.

[154]  J. Lieberman,et al.  Clozapine effects on tardive dyskinesia. , 1989, Psychopharmacology bulletin.

[155]  J. Overall,et al.  Tardive and withdrawal dyskinesia in autistic children: a prospective study. , 1988, Psychopharmacology bulletin.

[156]  A. Medalia,et al.  The effects of neuroleptics on neuropsychological test results of schizophrenics. , 1988, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[157]  T. Putten,et al.  Phenothiazine-induced decompensation. , 1974, Archives of general psychiatry.